Citichem India

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: INE0A8401016
  • NSEID:
  • BSEID: 544324
INR
16.00
0.00 (0.00%)
BSENSE

Jul 17, 03:30 PM

BSE+NSE Vol: 2000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.0 k (400.00%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

61.54%

Why is Citichem India Ltd falling/rising?

19-Jul-2026

As of 18-Jul, Citichem India Ltd's stock price is at 16.00, unchanged from the previous session. The stock has significantly underperformed the Sensex, with declines of 31.62% year-to-date and 42.32% over the past year, alongside erratic trading patterns and low liquidity.

As of 18-Jul, Citichem India Ltd's stock price is currently at 16.00, showing no change from the previous trading session. The stock has been underperforming significantly compared to the benchmark Sensex, with a decline of 2.44% over the past week and 5.88% over the past month, while the Sensex has gained 0.75% and 1.29% respectively during those periods. Year-to-date, the stock has fallen by 31.62%, compared to an 8.30% decline in the Sensex, and it has decreased by 42.32% over the past year, while the Sensex has only fallen by 4.99%.<BR><BR>Today's performance indicates that Citichem India Ltd has underperformed its sector by 2.59%. Additionally, the stock has shown erratic trading patterns, not trading on 5 out of the last 20 days, which contributes to its volatility. It is also trading below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), indicating a bearish trend. <BR><BR>However, there has been a notable increase in investor participation, with a delivery volume of 14,000 shares on July 8, which is up by 105.88% against the 5-day average delivery volume. Despite this rise in participation, the overall liquidity remains low, with the stock being liquid enough for trades of Rs 0 crore based on 2% of the 5-day average traded value. <BR><BR>In summary, the combination of significant underperformance against the benchmark, declining stock price trends, and erratic trading behavior are the primary reasons for the falling stock price of Citichem India Ltd.

View full answer

Which are the latest news on Citichem India?

18-Jul-2026

What does Citichem India do?

11-Jun-2026

Citichem India Ltd, a micro-cap company established in 1992, operates in the miscellaneous industry and reported net sales of 1 Cr and a net profit of 0 Cr for June 2024. Key metrics include a market cap of INR 12 Cr, a P/E ratio of 12.00, and a debt-equity ratio of 0.34.

Overview:<BR>Citichem India Ltd operates in the miscellaneous industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Citichem India Limited was incorporated in 1992 as Citichem Alkalies (Bombay) Private Limited. The company was later converted into a public limited company and renamed Citichem Alkalies (Bombay) Limited in 1999. The most recent quarterly results reported net sales and net profit for June 2024.<BR><BR>Financial Snapshot:<BR>Net Sales: 1 Cr (Quarterly Results - Jun 2024) <BR>Net Profit: 0 Cr (Quarterly Results - Jun 2024) <BR>Market-cap value: INR 12 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 12.00 <BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.34 <BR>Return on Equity: 4.74% <BR>Price-to-Book: 0.58 <BR><BR>Contact Details:<BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

View full answer

How big is Citichem India?

11-Jun-2026

No Data Available for the Stock

Who are the peers of the Citichem India?

11-Jun-2026

Citichem India's peers include Neelkanth Rock, Reetech Intl, Mayur Floorings, Milestone Global, Gala Global, Antarctica, Veritaas Adver., Supreme Impex, and Winny Immigratio. Citichem India has below-average management risk, growth, and capital structure, with a 1-year return of -36.06%, significantly lower than Neelkanth Rock's 81.66%.

Peers: The peers of Citichem India are Neelkanth Rock, Reetech Intl, Mayur Floorings, Milestone Global, Gala Global, Antarctica, Veritaas Adver., Supreme Impex, and Winny Immigratio.<BR><BR>Quality Snapshot: Excellent management risk is observed at Veritaas Adver. and Supreme Impex, while Average management risk is found at Citichem India. Below Average management risk is noted at Reetech Intl, Mayur Floorings, Milestone Global, Gala Global, Antarctica, and Winny Immigratio. Growth is Good at Antarctica and Veritaas Adver., while Below Average growth is seen at Citichem India, Reetech Intl, Mayur Floorings, Milestone Global, Gala Global, Supreme Impex, and Winny Immigratio. Capital Structure is Good at Milestone Global, while Below Average capital structure is found at Citichem India, Reetech Intl, Mayur Floorings, Gala Global, Antarctica, Supreme Impex, and Winny Immigratio.<BR><BR>Return Snapshot: Neelkanth Rock has the highest 1-year return at 81.66%, while Citichem India has the lowest at -36.06%. Citichem India's return is significantly lower than Neelkanth Rock's. Additionally, the six-month return is negative for Citichem India, Milestone Global, Gala Global, and Winny Immigratio.

View full answer

When is the next results date for Citichem India Ltd?

27-May-2026

The next results date for Citichem India Ltd is 30 May 2026.

The next results date for Citichem India Ltd is scheduled for 30 May 2026.

View full answer

Is Citichem India overvalued or undervalued?

18-Nov-2025

As of November 17, 2025, Citichem India is fairly valued with a PE ratio of 14.93, lower than its expensive peers, and has underperformed the Sensex recently, indicating a reasonable stock price relative to its earnings and book value.

As of 17 November 2025, Citichem India has moved from a very attractive to a fair valuation grade. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 14.93, an EV to EBITDA of 15.43, and a Price to Book Value of 0.88, which suggest that the stock is reasonably priced relative to its earnings and book value.<BR><BR>In comparison to its peers, Citichem India stands out with a PE ratio lower than that of Solar Industries at 95.31 and Gujarat Fluoroch at 57.85, both of which are considered very expensive. Additionally, Godrej Industries, which is rated attractive, has a PE ratio of 37.63, indicating that Citichem India may offer a more favorable valuation in the current market. Recent stock performance has lagged behind the Sensex, with a 1-month return of -0.52%, contrasting with the Sensex's 1.19% gain, further emphasizing the fair valuation of Citichem India.

View full answer

How has been the historical performance of Citichem India?

15-Nov-2025

Citichem India's historical performance over the past three fiscal years shows fluctuating net sales and profitability, with net sales declining to 18.70 crore in March 2025, but a significant increase in operating income to 54.38 crore. Despite challenges, the company maintained a stable asset base of 69.92 crore and improved operating profit to 1.98 crore.

Answer:<BR>The historical performance of Citichem India shows a mixed trend over the past three fiscal years, with fluctuations in net sales, operating income, and profitability.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Citichem India reported net sales of 18.70 crore, a decline from 19.61 crore in March 2024 and 20.94 crore in March 2023. However, the company saw a significant increase in other operating income, rising to 35.68 crore in March 2025 from zero in the previous two years, leading to a total operating income of 54.38 crore, up from 19.61 crore in March 2024 and 20.94 crore in March 2023. Total expenditure also increased to 52.76 crore in March 2025, compared to 17.81 crore in March 2024 and 20.36 crore in March 2023. Operating profit (PBDIT) was reported at 1.98 crore for March 2025, slightly up from 1.80 crore in March 2024 and significantly higher than 0.58 crore in March 2023. Profit before tax was 1.66 crore in March 2025, down from 1.71 crore in March 2024, while profit after tax was 1.23 crore, a decrease from 1.39 crore in March 2024 but an increase from 0.36 crore in March 2023. The company's total assets stood at 69.92 crore in March 2025, a slight increase from 69.33 crore in March 2024, while total liabilities were 69.92 crore, indicating a stable financial position. Cash flow from operating activities was negative at -11.00 crore in March 2025, contrasting with a net cash inflow of 3.00 crore for the same period, reflecting a reliance on financing activities for liquidity. Overall, while Citichem India has experienced challenges in sales and profitability, it has managed to enhance its operating income and maintain a stable asset base.

View full answer

Who are the top shareholders of the Citichem India?

06-Jun-2025

The top shareholder of Citichem India is Arif Esmail Merchant, holding 27.83%, with no pledged promoter holdings. Globopac India Private Limited is the largest public shareholder at 4.41%, while individual investors own 30.64% of the company.

The top shareholders of Citichem India include the promoters, with Arif Esmail Merchant holding the largest share at 27.83%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) involved. The highest public shareholder is Globopac India Private Limited, which holds 4.41%. Additionally, individual investors collectively own 30.64% of the company.

View full answer

Has Citichem India declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Miscellaneous

stock-summary
Market cap

INR 11 Cr (Micro Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.34

stock-summary
Return on Equity

4.74%

stock-summary
Price to Book

0.52

Revenue and Profits:
Net Sales:
1 Cr
(Quarterly Results - Jun 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.23%
0%
-1.23%
6 Months
-20.0%
0%
-20.0%
1 Year
-42.32%
0%
-42.32%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Citichem India for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Board Meeting Outcome for Outcome Of The Board Meeting Approving Financial Results For The Fourth Quarter Ended On 31St March 2026

30-May-2026 | Source : BSE

This is in reference to our earlier intimation dated 26th May 2026 pursuant to Regulation 29 read with Regulation 30 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) regarding holding of Board Meeting on 30th May 2026 In this regard please note that the Board of Directors at its meeting held today i e 30th May 2026 has inter alia approved the Audited Financial Results of the Company for the year ended 31st March 2026 Accordingly we are enclosing herewith Audited Standalone Financial Results for the year ended 31st March 2026 along with Auditors Report thereon. The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone Financial Results for the year ended 31 March 2026. The meeting of the Board of Directors of the Company commenced at 7:30 p.m. and concluded at 9:00 pm. Kindly take the same on record.

Audited Standalone Financial Results For The Fourth Quarter Ended 31St March 2026

30-May-2026 | Source : BSE

Audited Standalone Financial Results for the Fourth Quarter ended 31st March 2026

Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Year Ended 31St March 2026.

26-May-2026 | Source : BSE

Citichem India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday 30th May 2026 inter alia to consider and approve the Audited Standalone Financial Results of the Company for the year ended 31st March 2026.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-11.00%
EBIT Growth (5y)
19.11%
EBIT to Interest (avg)
1.31
Debt to EBITDA (avg)
2.98
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
1.81
Tax Ratio
27.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.85%
ROE (avg)
5.43%

Valuation key factors

Factor
Value
P/E Ratio
11
Industry P/E
0
Price to Book Value
0.52
EV to EBIT
14.25
EV to EBITDA
13.61
EV to Capital Employed
0.64
EV to Sales
1.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.47%
ROE (Latest)
4.74%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Dow Theory
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Arif Esmail Merchant (27.83%)

Highest Public shareholder

Globopac India Private Limited (4.41%)

Individual Investors Holdings

29.64%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.10",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.11",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.20",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-10.00%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -49.94% vs 919.16% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -38.74% vs 825.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.52",
          "val2": "17.02",
          "chgp": "-49.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.54",
          "val2": "1.45",
          "chgp": "-62.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.31",
          "chgp": "-16.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.68",
          "val2": "1.11",
          "chgp": "-38.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.34%",
          "val2": "8.52%",
          "chgp": "-2.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.62",
          "val2": "2.77",
          "chgp": "247.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.43",
          "val2": "0.06",
          "chgp": "616.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.88",
          "val2": "0.32",
          "chgp": "175.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.84%",
          "val2": "2.17%",
          "chgp": "1.67%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -4.64% vs -6.35% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -11.51% vs 286.11% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.70",
          "val2": "19.61",
          "chgp": "-4.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.62",
          "val2": "1.80",
          "chgp": "-10.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.31",
          "val2": "0.07",
          "chgp": "342.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.23",
          "val2": "1.39",
          "chgp": "-11.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.66%",
          "val2": "9.18%",
          "chgp": "-0.52%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'24 - QoQstock-summary

Jun'24
Change(%)
Net Sales
1.10
NA
NA
Operating Profit (PBDIT) excl Other Income
-0.11
NA
NA
Interest
0.00
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
0.20
NA
NA
Operating Profit Margin (Excl OI)
-10.00%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Mar'25
Change(%)
Net Sales
8.52
17.02
-49.94%
Operating Profit (PBDIT) excl Other Income
0.54
1.45
-62.76%
Interest
0.26
0.31
-16.13%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.68
1.11
-38.74%
Operating Profit Margin (Excl OI)
6.34%
8.52%
-2.18%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -49.94% vs 919.16% in Mar 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -38.74% vs 825.00% in Mar 2025

Nine Monthly Results Snapshot (Standalone) - Jun'24stock-summary

Jun'24
Jun'24
Change(%)
Net Sales
9.62
2.77
247.29%
Operating Profit (PBDIT) excl Other Income
0.43
0.06
616.67%
Interest
0.26
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.88
0.32
175.00%
Operating Profit Margin (Excl OI)
3.84%
2.17%
1.67%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
18.70
19.61
-4.64%
Operating Profit (PBDIT) excl Other Income
1.62
1.80
-10.00%
Interest
0.31
0.07
342.86%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.23
1.39
-11.51%
Operating Profit Margin (Excl OI)
8.66%
9.18%
-0.52%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -4.64% vs -6.35% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -11.51% vs 286.11% in Mar 2024

stock-summaryCompany CV
About Citichem India Ltd stock-summary
stock-summary
Citichem India Ltd
Micro Cap
Miscellaneous
Citichem India Limited was incorporated as `Citichem Alkalies (Bombay) Private Limited' dated March 18, 1992 at Maharashtra. Further, Company was converted into public limited company and consequently name of Company was changed to `Citichem Alkalies (Bombay) Limited' dated March 23, 1999.
Company Coordinates stock-summary
Icon
No Company Details Available